BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33431235)

  • 1. Development of Sarcopenia in Patients With Bladder Cancer: A Systematic Review.
    Hansen TTD; Omland LH; von Heymann A; Johansen C; Clausen MB; Suetta C; Pappot H; Rafn BS
    Semin Oncol Nurs; 2021 Feb; 37(1):151108. PubMed ID: 33431235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
    Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
    Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
    Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is sarcopenia a morbi-mortality factor in the treatment of localized muscle-invasive bladder cancer?].
    Fraisse G; Renard Y; Lebacle C; Masson-Lecomte A; Desgrandchamps F; Hennequin C; Bessede T; Irani J
    Prog Urol; 2020 Jan; 30(1):41-50. PubMed ID: 31818689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia.
    Ferini G; Cacciola A; Parisi S; Lillo S; Molino L; Tamburella C; Davi V; Napoli I; Platania A; Settineri N; Iati G; Pontoriero A; Pergolizzi S; Santacaterina A
    In Vivo; 2021; 35(1):571-578. PubMed ID: 33402511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
    BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    Lyon TD; Frank I; Takahashi N; Boorjian SA; Moynagh MR; Shah PH; Tarrell RF; Cheville JC; Viers BR; Tollefson MK
    Clin Genitourin Cancer; 2019 Jun; 17(3):216-222.e5. PubMed ID: 31060857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
    Ha YS; Kim SW; Kwon TG; Chung SK; Yoo ES
    Int Braz J Urol; 2019; 45(4):686-694. PubMed ID: 30901172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis.
    Buentzel J; Heinz J; Bleckmann A; Bauer C; Röver C; Bohnenberger H; Saha S; Hinterthaner M; Baraki H; Kutschka I; Emmert A
    Anticancer Res; 2019 Sep; 39(9):4603-4612. PubMed ID: 31519557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia in Urinary Bladder Cancer: Definition, Prevalence and Prognostic Value in Survival.
    Bellos TC; Tzelves LI; Manolitsis IS; Katsimperis SN; Berdempes MV; Skolarikos A; Karakousis ND
    Maedica (Bucur); 2022 Jun; 17(2):427-435. PubMed ID: 36032591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia as a predictor of complications and survival following radical cystectomy.
    Smith AB; Deal AM; Yu H; Boyd B; Matthews J; Wallen EM; Pruthi RS; Woods ME; Muss H; Nielsen ME
    J Urol; 2014 Jun; 191(6):1714-20. PubMed ID: 24423437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
    Baracos VE; Arribas L
    Ann Oncol; 2018 Feb; 29(suppl_2):ii1-ii9. PubMed ID: 29506228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.
    Levolger S; van Vugt JL; de Bruin RW; IJzermans JN
    Br J Surg; 2015 Nov; 102(12):1448-58. PubMed ID: 26375617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
    Stangl-Kremser J; D'Andrea D; Vartolomei M; Abufaraj M; Goldner G; Baltzer P; Shariat SF; Tamandl D
    Urol Oncol; 2019 Jun; 37(6):372-379. PubMed ID: 30578161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
    Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
    Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
    Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
    Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis.
    Oliveira VHF; Borsari AL; Webel AR; Erlandson KM; Deminice R
    Eur J Clin Nutr; 2020 Jul; 74(7):1009-1021. PubMed ID: 32341489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
    Yamashita S; Iguchi T; Koike H; Wakamiya T; Kikkawa K; Kohjimoto Y; Hara I
    Int J Urol; 2021 Jul; 28(7):757-762. PubMed ID: 33821510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of sarcopenia in older patients with colorectal cancer.
    Broughman JR; Williams GR; Deal AM; Yu H; Nyrop KA; Alston SM; Gordon BB; Sanoff HK; Muss HB
    J Geriatr Oncol; 2015 Nov; 6(6):442-5. PubMed ID: 26365898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
    Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.